The H2-Penetratin peptide has been demonstrated to bind the ATPase domain of HSC70 and exert its effects, such as growth inhibition, in human breast cancer cells by preventing the interaction between BAG-1 and HSC7020. Here, HSPA8 is linked to breast carcinoma.